Clinical Trial Update: Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing delafloxacin IV and oral suspension to best available therapy in patients with surgical site infection; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Delafloxacin (delafloxacin)

Snippet

Sponsor: Menarini Group | Conditions: Surgical Site Infection | Phase 3 | Status: TERMINATED | Results posted: 2021-10-29